<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NYSE:CRL (USA) Also Trade In: Germany

Charles River Laboratories International Inc $ 126.38 0 (0%)

Volume:
1
Avg Vol (1m):
336,582
Market Cap $:
6.19 Bil
Enterprise Value $:
8.19 Bil
P/E (TTM):
28.69
P/B:
4.21
Warning! GuruFocus has detected 1 Severe warning sign with CRL. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

CRL News and Headlines - Charles River Laboratories International

GuruFocus Articles Total 34
  • 1
  • 2

NEW YORK, May 03, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. (“Charles River” or the “Company”) (: CRL).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.

The investigation concerns whether Charles River and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

On April 30, 2019, Charles River disclosed that a “highly sophisticated, well-resourced intruder” accessed

0 Views    Marketwired    2019-05-03 20:00

NEW YORK, May 02, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Charles River Laboratories International, Inc. (: CRL).  Our investigation concerns whether Charles River has violated the federal securities laws and/or engaged in other unlawful business practices.

Click here to participate in the action.

On April 30, 2019, Charles River disclosed that a “highly sophisticated, well-resourced intruder” accessed its information system in mid-March 2019, and that data belonging to “approximately 1% of Charles River’s

0 Views    Marketwired    2019-05-03 04:00

PR Newswire

NEW YORK, May 1, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.

The investigation concerns whether Charles River and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

On April 30, 2019,

0 Views    PRNewswire    2019-05-02 04:00

NEW YORK, March 25, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Bristol-Myers Squibb Company (:BMY), AutoNation, Inc. (:AN), FirstEnergy Corporation (:FE), Charles River Laboratories International, Inc. (:CRL), Yum! Brands, Inc. (:YUM), and AGNC Investment Corp. (AGNC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links

0 Views    Marketwired    2019-03-25 12:00
Dow Jones gains 0.46%

The Dow Jones Industrial Average closed at 25,543.27 on Wednesday with a gain of 117.51 points or 0.46%. The S&P 500 closed at 2,753.03 for a gain of 8.30 points or 0.30%. The Nasdaq Composite closed at 7,420.38 for a gain of 5.76 points or 0.08%. The VIX Volatility Index was higher at 15.52 for a gain of 0.09 points or 0.58%.

Wednesday’s market movers

U.S. stock market indexes closed higher for a third day as progress in political negotiations helped valuations. President Trump is expected to sign the latest agreement reached in Congress to keep the government

167 Views    Julie Young    2019-02-13 22:02

NEW YORK, Jan. 18, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Electronic Arts Inc. (EA), Charles River Laboratories International, Inc. (:CRL), Cooper-Standard Holdings Inc. (:CPS), Five Below, Inc. (FIVE), Emerge Energy Services LP (:EMES), and Hornbeck Offshore Services (:HOS), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers

0 Views    Marketwired    2019-01-18 13:02
Cardinal Health tops the list

According to the GuruFocus All-In-One Screener, the following health care stocks are popular among guru investors.

Cardinal Health Inc. (CAH) is held by 12 gurus. The company, which provides services and products for hospital systems and physicians' offices, has a market cap of $13.5 billion. Its revenue of $139.381 billion has grown 5.10% over a 10-year period.

The stock is trading with a price-earnings ratio of 19.01. As of Friday, the share price of $44.7 is 40.20% below its 52-week high and 1.57% above its 52-week low. Over the last 10 years, it has returned a 90% gain.

The

118 Views    Tiziano Frateschi    2018-12-21 21:07

NEW YORK, Dec. 07, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Raytheon Company (:RTN), S&P Global Inc. (:SPGI), Teledyne Technologies Incorporated (:TDY), Nordstrom, Inc. (:JWN), Charles River Laboratories International, Inc. (:CRL), and U.S. Silica Holdings, Inc. (:SLCA), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at

0 Views    Marketwired    2018-12-07 13:01

NEW YORK, Oct. 29, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Polaris Industries Inc. (:PII), NIKE, Inc. (:NKE), Charles River Laboratories International, Inc. (:CRL), Actuant Corporation (:ATU), Caesarstone Ltd. (CSTE), and Enzo Biochem, Inc. (:ENZ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links

4 Views    Marketwired    2018-10-29 16:01
15 gurus hold shares of Quest Diagnostics

According to the GuruFocus All-In-One Screener, the following health care stocks are popular among guru investors.

Fifteen gurus are invested in Quest Diagnostics Inc. (DGX). The provider of diagnostic testing, information and services, has a market cap of $14.72 billion. Its revenue of $7.67 billion has increased 4.70% over a 10-year period.

The stock is trading with a price-book ratio of 2.81. As of Wednesday, the price of $107.69 is 7.60% below its 52-week high and 19.47% above its 52-week low. Over the last 10 years, it has returned a gain of 115%.

The company’s largest shareholder among

82 Views    Tiziano Frateschi    2018-09-26 15:46

NEW YORK, Aug. 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Myriad Genetics, Inc. (MYGN), Celldex Therapeutics, Inc. (CLDX), Charles River Laboratories International, Inc. (:CRL), Louisiana-Pacific Corporation (:LPX), Integrated Device Technology, Inc. (IDTI), and Beazer Homes USA, Inc. (:BZH), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers

0 Views    Marketwired    2018-08-01 12:01

PR Newswire

NEW YORK, May 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Charles River Laboratories International, Inc. (NYSE: CRL).

If you are a shareholder of Charles River Laboratories International, Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us

0 Views    PRNewswire    2018-05-29 20:01
Guru's largest 1st-quarter buys

John Rogers (Trades, Portfolio) is the founder of Ariel Investment LLC, which he started in 1983. He manages a portfolio composed of 188 stocks with a total value of $8.505 billion. During the first quarter the guru bought shares in the following stocks:

Cardinal Health Inc. (CAH)’s stake was boosted by 1,944.54% with an impact of 0.68% on the portfolio.

e83a8809be69e38a2d808d98554e1bf3.png

It is a health care services company that provides health care services and products for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. Its segments are pharmaceutical and

274 Views    Tiziano Frateschi    2017-06-05 18:43
These companies are the best undervalued stocks of the week

I evaluated 30 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. I also put each company through the ModernGraham valuation model based on Benjamin Graham's value investing formulas in order to determine an intrinsic value for each. Out of those 30 companies, only five were found to be undervalued or fairly valued and suitable for either Defensive or Enterprising Investors. Therefore, these companies are the best undervalued stocks of the week.

The Elite

The following companies were

603 Views    Benjamin Clark    2017-02-26 14:24
Guru stock highlight

Other holdings underperformed. Scientific research firm Charles River Laboratories Intl, Inc. (NYSE:CRL) slid –8.58% due to contracting customer spending and a general downturn in health care stocks. Like other similar firms, Charles River expanded over the last 15 years to be able to handle peak medical research, but as drug companies scaled back, there was clearly overcapacity. The company’s drug discovery business is still a bit slack. That said, many health care stocks slid this quarter during a huge rotation to financials. We think the current issues are largely cyclical but the secular push toward solving medical

97 Views    Holly LaFon    2017-01-20 21:56
Discussion of quarter and holdings

Entering the fourth quarter of 2016, it appeared domestic stocks would have a solid year and international equities a lackluster, yet positive one. After a divergent quarter, we had a great year in the U.S. and a flat year abroad. For 2016, the large-cap S&P 500 Index gained +11.96%, the small-cap Russell 2000 Index leapt +21.31%, while the developed-market MSCI EAFE Index eked out a +1.00% gain. As many know, the big surge after the surprising U.S. Presidential Election became known as the “Trump Bump.” The disparity between large-caps’ single digit fourth quarter gains and small-caps’ big run stems from

194 Views    Holly LaFon    2017-01-20 20:29
Staying the course when facing headwinds

August 24, 2016

Dear Fellow Shareholders:

For the fiscal year ended June 30, 2016, load-waived Class A shares of the Olstein Strategic Opportunities Fund had a return of -15.31% compared to total returns of 0.22% and -3.67% for the Russell 2500® Value Index and the Russell 2500® Index, respectively. For the three years ended June 30, 2016, load-waived Class A shares of the Olstein Strategic Opportunities Fund had an average annual return of 4.65% compared to average annual returns of 8.14% for the Russell 2500 Value Index and 8.61% for the Russell 2500 Index over the same time period.

Market

1142 Views    Holly LaFon    2016-09-01 18:20
'The active pursuit of above average investment returns'

Dear Fellow Shareholders:

For the quarter ended March 31, 2016, load-waived Class A shares of the Olstein Strategic Opportunities Fund appreciated 2.48%. During the same three-month period the Russell 2500 Value™ Index appreciated 3.33% and the Russell 2500™ Index appreciated 0.39%. For the three-year period ended March 31, 2016, load waived Class A shares of the Olstein Strategic Opportunities Fund had an average annual return of 7.30%, compared to average annual returns of 7.15% for the Russell 2500 Value Index and 8.16% for the Russell 2500 Index.

Outlook & Strategy

While many investors are nervous about volatility in equity markets,

909 Views    Holly LaFon    2016-06-07 15:49
Buys, sells, investment strategy

May 20, 2016

Dear Fellow Shareholders:

For the quarter ended March 31, 2016, Class C shares of the Olstein All Cap Value Fund appreciated 2.22%. During the same three-month period, the Russell 3000 Value® Index appreciated 1.64% and the Russell 3000® Index appreciated 0.97%. For the three-year period ended March 31, 2016, Class C shares of the Olstein All Cap Value Fund had an average annual return of 8.96%, compared to average annual returns of 9.08% and 11.15% for the Russell 3000 Value Index and the Russell 3000 Index, respectively.

Market Outlook

While many investors are nervous about equity markets,

1358 Views    Holly LaFon    2016-06-01 16:39

According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Charles River Laboratories International Inc, McKesson Corp, SolarCity Corp, and Select Medical Holdings Corp.

Charles River Laboratories International Inc (CRL): Chairman, President and CEO James C Foster sold 136,647 shares

Chairman, President and CEO of Charles River Laboratories International James C Foster sold 136,647 shares on 10/03/2014 at an average price of $62. Charles River Laboratories is a Delaware corporation that was incorporated in 1994. Charles River Laboratories has a market cap of $2.66 billion; its shares were traded at around $56.93 with a

896 Views    alicet236    2014-10-13 19:14

Headlines Total 99
  • 1

2019-10-08 $ 129.48 (-1.82%)
9:36am
2019-09-16 $ 134.3 (1.55%)
8:27am
2019-09-04 $ 131.71 (0.7%)
8:00am
2019-08-31
7:18am
2019-07-31 $ 134.54 (-4.66%)
3:05pm
10:20am
7:25am
2019-07-30 $ 141.11 (0.94%)
10:45am
2019-07-24 $ 139.84 (1.75%)
9:32am
2019-06-13 $ 131.97 (-0.67%)
8:37pm
2019-05-07 $ 134.26 (-5.66%)
3:23pm
2:44pm
12:54pm
7:15am
2019-05-03 $ 142.41 (1.92%)
3:00pm
2019-05-02 $ 139.73 (1.73%)
11:00pm
2019-04-30 $ 140.47 (-1.44%)
9:32am
2019-04-12 $ 144.39 (0.12%)
10:52am
9:32am
2019-04-05 $ 143.9 (0.01%)
9:00am
2019-04-04 $ 143.89 (-3.14%)
9:41am
2019-04-03 $ 148.55 (0.66%)
8:19am
2019-04-02 $ 147.58 (1.43%)
9:27am
8:15am
2019-03-15 $ 143.48 (1.77%)
8:17am
2019-03-12 $ 140.49 (0.1%)
8:28pm
2019-03-11 $ 140.35 (1.74%)
12:27pm
2019-03-06 $ 138.03 (-1.95%)
9:23am
2019-03-04 $ 141.2 (-2.01%)
2:35pm
12:22pm
12:00pm
8:20am
2019-03-01 $ 144.09 (1.35%)
6:05am
2019-02-27 $ 142.57 (1.32%)
8:57am
2019-02-26 $ 140.71 (-3.17%)
7:55am
2019-02-25 $ 145.31 (0.44%)
8:15am
2019-02-18 $ 140.86 (%)
3:46pm
10:59am
6:50am
2019-02-13 $ 139.12 (7.68%)
6:26pm
9:16am
7:20am
2019-02-06 $ 126.49 (0.07%)
9:30am
2019-01-09 $ 117.99 (0.35%)
1:17pm
2018-12-10 $ 127.71 (-0.89%)
11:33am
2018-12-03 $ 137.23 (1.76%)
8:30am
2018-11-07 $ 136.23 (8.86%)
5:49pm
10:16am
7:25am
2018-10-01 $ 133.55 (-0.74%)
12:06pm
2018-09-06 $ 125.5 (0.98%)
3:09pm
2018-08-14 $ 120.14 (0.18%)
1:43pm
2018-08-09 $ 121.76 (-1.95%)
12:23am
2018-08-08 $ 124.18 (-3.3%)
2:24pm
8:52am
7:25am
6:10am
2018-08-03 $ 127.73 (0.66%)
7:31am
2018-07-18 $ 120.42 (0.39%)
2:38am
2018-07-04 $ 113.24 (%)
3:25am
2018-06-13 $ 113.87 (-1.8%)
1:40pm
2018-06-09
11:12am
2018-05-16 $ 103.73 (-0.41%)
1:59pm
2018-05-11 $ 105.53 (0.92%)
11:15am
2018-05-10 $ 104.57 (-0.57%)
3:15pm
2018-05-09 $ 105.17 (0.22%)
8:00am
2018-05-07 $ 105.36 (-0.54%)
2:08pm
2018-03-06 $ 111.32 (2.82%)
2:41pm
2018-02-19 $ 108.11 (%)
9:57am
7:29am
2018-02-13 $ 107.66 (5.56%)
2:03pm
2018-02-09 $ 99.77 (1.61%)
7:55am
2017-12-11 $ 103.9 (0.06%)
8:23am
2017-12-07 $ 103.13 (0.63%)
6:50pm
2017-11-17 $ 101.39 (-0.08%)
3:10am
2017-11-16 $ 101.47 (1.04%)
6:47am
2017-11-15 $ 100.43 (-0.49%)
8:28pm
2017-11-13 $ 101.93 (-0.19%)
4:56am
2017-11-08 $ 117.8 (0.78%)
7:50am
2017-11-06 $ 117.35 (-0.34%)
5:18pm
2017-11-03 $ 117.75 (0.53%)
2:11pm
2017-09-12 $ 109.26 (0.64%)
3:40pm
2017-08-18 $ 99.98 (0.27%)
2:11pm
2017-07-26 $ 99.44 (-0.75%)
11:11am
2017-05-10 $ 90.22 (-1.61%)
9:10am
2017-01-20 $ 79.86 (-0.26%)
3:56pm
2014-10-13 $ 56.46 (-0.7%)
2:14pm
2014-07-22 $ 53.41 (1.54%)
3:06pm
2012-01-11 $ 31.34 (-3.48%)
2:05pm
2010-11-04 $ 31.91 (-3.07%)
3:49pm
2010-08-03 $ 30.06 (0.64%)
4:35pm
2010-04-29 $ 34.28 (0.26%)
12:15pm
2009-11-04 $ 34.07 (-8.17%)
10:18am
2009-08-06 $ 31.68 (1.08%)
12:21am
2009-05-07 $ 27.69 (-1.56%)
12:03am
2006-10-06 $ 43.85 (0.48%)
3:27pm
1969-12-31
7:00pm
7:00pm
7:00pm
Total 99
  • 1